Pages that link to "Q38480101"

The following pages link to Genetic regulation of behavioral and neuronal responses to fluoxetine (Q38480101):

Displaying 44 items.

• Evaluating genetic markers and neurobiochemical analytes for fluoxetine response using a panel of mouse inbred strains (Q24632901) (← links)
• The GABAβ receptor as a target for antidepressant drug action (Q28476654) (← links)
• Neurogenomic evidence for a shared mechanism of the antidepressant effects of exercise and chronic fluoxetine in mice (Q28482529) (← links)
• Synaptosomal-associated protein 25 mutation induces immaturity of the dentate granule cells of adult mice (Q30456114) (← links)
• Gene-class analysis of expression patterns induced by psychoactive pharmaceutical exposure in fathead minnow (Pimephales promelas) indicates induction of neuronal systems. (Q30486393) (← links)
• Quantitative trait locus analysis identifies Gabra3 as a regulator of behavioral despair in mice (Q30495091) (← links)
• Fluoxetine induces input-specific hippocampal dendritic spine remodeling along the septotemporal axis in adulthood and middle age. (Q30667140) (← links)
• Biomarkers of anhedonic-like behavior, antidepressant drug refraction, and stress resilience in a rat model of depression (Q31030055) (← links)
• The Neural/Immune Gene Ontology: clipping the Gene Ontology for neurological and immunological systems (Q33690093) (← links)
• Open questions in current models of antidepressant action (Q33767182) (← links)
• Phenotypic characterization of a genetically diverse panel of mice for behavioral despair and anxiety (Q33785836) (← links)
• Enhanced sensitivity of the MRL/MpJ mouse to the neuroplastic and behavioral effects of acute and chronic antidepressant treatments (Q33847504) (← links)
• Effect of fluoxetine on disease progression in a mouse model of ALS. (Q33900692) (← links)
• Comparison of neurogenic effects of fluoxetine, duloxetine and running in mice. (Q33907598) (← links)
• Hippocampal HDAC4 contributes to postnatal fluoxetine-evoked depression-like behavior. (Q33923651) (← links)
• Reversal of hippocampal neuronal maturation by serotonergic antidepressants. (Q33929389) (← links)
• Identifying individual differences of fluoxetine response in juvenile rhesus monkeys by metabolite profiling (Q34657982) (← links)
• Regulation and function of adult neurogenesis: from genes to cognition (Q34790135) (← links)
• Targeting the hippocampal mossy fiber synapse for the treatment of psychiatric disorders. (Q34917667) (← links)
• The current state of the neurogenic theory of depression and anxiety (Q34943860) (← links)
• The effect of immature adult-born dentate granule cells on hyponeophagial behavior is related to their roles in learning and memory (Q35153468) (← links)
• Fluoxetine rescues impaired hippocampal neurogenesis in a transgenic A53T synuclein mouse model (Q35654251) (← links)
• Chronic fluoxetine selectively upregulates dopamine D₁-like receptors in the hippocampus (Q35892753) (← links)
• The role of serotonin receptor subtypes in treating depression: a review of animal studies (Q36031101) (← links)
• Antidepressant therapy in epilepsy: can treating the comorbidities affect the underlying disorder? (Q36709214) (← links)
• Immature dentate gyrus: an endophenotype of neuropsychiatric disorders. (Q36960113) (← links)
• Depression: A repair response to stress-induced neuronal microdamage that can grade into a chronic neuroinflammatory condition? (Q37183514) (← links)
• Enhanced sensitivity of the MRL/MpJ mouse to the neuroplastic and behavioral effects of chronic antidepressant treatments (Q37189002) (← links)
• Neurogenesis and affective disorders (Q37852107) (← links)
• Psychotropic Drug Effects on Gene Transcriptomics Relevant to Alzheimer Disease (Q37852542) (← links)
• Is neurogenesis relevant in depression and in the mechanism of antidepressant drug action? A critical review (Q37969149) (← links)
• Neuroprotective effects of psychotropic drugs in Huntington's disease (Q38163877) (← links)
• The dilemma of treatments for epileptic patients with depression (Q38255835) (← links)
• The neuroprotective disease-modifying potential of psychotropics in Parkinson's disease (Q40299879) (← links)
• Electroconvulsive therapy modulates plasma pigment epithelium-derived factor in depression: a proteomics study (Q42290537) (← links)
• Blocked inhibitory serine-phosphorylation of glycogen synthase kinase-3alpha/beta impairs in vivo neural precursor cell proliferation (Q42559938) (← links)
• Profiling of behavioral changes and hippocampal gene expression in mice chronically treated with the SSRI paroxetine (Q46482293) (← links)
• Profiling and Co-expression Network Analysis of Learned Helplessness Regulated mRNAs and lncRNAs in the Mouse Hippocampus (Q47644469) (← links)
• Kdm6b and Pmepa1 as Targets of Bioelectrically and Behaviorally Induced Activin A Signaling (Q48077289) (← links)
• Lithium-induced effects on adult hippocampal neurogenesis are topographically segregated along the dorso-ventral axis of stressed mice (Q48820635) (← links)
• Mouse Strain Affects Behavioral and Neuroendocrine Stress Responses Following Administration of Probiotic Lactobacillus rhamnosus JB-1 or Traditional Antidepressant Fluoxetine. (Q55047572) (← links)
• Anxiety Specific Response and Contribution of Active Hippocampal Neural Stem Cells to Chronic Pain Through Wnt/β-Catenin Signaling in Mice (Q58705518) (← links)
• Targeting Serotonin Transporters in the Treatment of Juvenile and Adolescent Depression (Q64094994) (← links)
• Obligatory roles of dopamine D1 receptors in the dentate gyrus in antidepressant actions of a selective serotonin reuptake inhibitor, fluoxetine (Q90371588) (← links)